A Brief Intervention for Cannabis Use

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-25
SponsorMedical University of South Carolina

About this trial

The purpose of this study is to compare two brief interventions targeting potentially problematic cannabis use in emerging adults (ages 18-25). Brief interventions are two 40-50 minute sessions separated by 1 week. Eligible emerging adults will complete a detailed cannabis assessment (biological and self-report), followed by one of the two brief interventions, and four follow-up assessments: one immediately after the second session and at 1-, 3-, and 6-months post-intervention. Assignment to the brief intervention is random. Salivary samples will be collected at baseline, post-intervention, and all follow-ups, for a total of 5 samples, to be tested for tetrahydrocannabinol (THC) and cannabidiol (CBD).

Eligibility criteria

Qualifiers

Ages 18-25

Self-Report report cannabis use on at least 20 days of the past 30 days

Submit a positive urine cannabinoid test

Disqualifiers

Currently engaged in substance use treatment for any type of substance use or currently treatment seeking

History of substance use treatment for any type of substance

Severe alcohol use disorder or indication of any substance use disorder requiring a higher level of care (AUDIT score ≥14 or DUDIT score ≥2 for women, ≥6 for men)

Significant or acutely unstable medical or psychiatric problems (i.e., psychosis, mania) that would contraindicate research procedures, interfere with safety, compromise data integrity, or preclude consistent study participation (Screening psychosis score =7)

Trial design

Treatments tested in this trial

  • Health Education (HealthEdu)
  • Bloom

Treatment groups

62 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Medical University of South Carolina

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator